Mycoplasma genitalium Antimicrobial Resistance in Community and Sexual Health Clinic Patients, Auckland, New Zealand.


Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
02 2020
Historique:
entrez: 22 1 2020
pubmed: 22 1 2020
medline: 5 1 2021
Statut: ppublish

Résumé

Our retrospective study compared genotypic antimicrobial resistance in Mycoplasma genitalium-positive specimens collected from 48 community and 33 sexual health clinic (SHC) patients. Macrolide resistance was similar in community (75%) and SHC (76%) patients. We observed no significant difference in fluoroquinolone resistance between community (19%) and SHC (27%) patients (p = 0.66).

Identifiants

pubmed: 31961302
doi: 10.3201/eid2602.190533
pmc: PMC6986824
doi:

Substances chimiques

Anti-Bacterial Agents 0
Fluoroquinolones 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

332-335

Références

PLoS One. 2018 Jun 8;13(6):e0198355
pubmed: 29883482
Antimicrob Agents Chemother. 2000 Oct;44(10):2719-27
pubmed: 10991851
J Clin Microbiol. 2017 Nov;55(11):3242-3248
pubmed: 28878004
Int J Antimicrob Agents. 2010 Sep;36(3):255-8
pubmed: 20580532
J Clin Microbiol. 2004 Feb;42(2):683-92
pubmed: 14766837
Antimicrob Agents Chemother. 2013 Apr;57(4):1772-6
pubmed: 23357772
Diagn Microbiol Infect Dis. 2016 Oct;86(2):221-3
pubmed: 27448452
J Antimicrob Chemother. 2014 Sep;69(9):2376-82
pubmed: 24894419
J Clin Microbiol. 2013 Jul;51(7):2245-9
pubmed: 23658265
J Antimicrob Chemother. 2001 Nov;48(5):742-4
pubmed: 11679571
Emerg Infect Dis. 2018 Feb;24(2):328-335
pubmed: 29350154
J Clin Microbiol. 2017 Jul;55(7):2280-2282
pubmed: 28468853
J Infect Dis. 2017 Jul 15;216(suppl_2):S420-S426
pubmed: 28838079
Emerg Infect Dis. 2017 May;23(5):809-812
pubmed: 28418319
Int J STD AIDS. 2013 Oct;24(10):822-8
pubmed: 24052013

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH